Pathology At The Speed Of Thought

Course Faculty

Updates of the WHO Classification of Brain and Pituitary Tumors

Updates of the WHO Classification of Brain and Pituitary Tumors

September 19 - 20, 2019

Physicians Can Earn A Maximum Of 16 AMA PRA Category 1 Credits
Physicians Can Earn A Maximum Of 16 SAM Credit Hours

Arie Perry

Arie Perry, MD
University of California, San Francisco

Course Director

Arie Perry is a Professor at the University of California in San Francisco, where he serves as the Director of the Neuropathology Division and the Neuropathology Fellowship program. He received his MD and residency training at UT Southwestern Medical Center in Dallas, Texas, followed by fellowships in surgical pathology, neuropathology, and molecular cytogenetics research at the Mayo Clinic in Rochester, MN. His interests have focused mostly on classification, grading, and molecular characterization of both adult and pediatric brain tumors. He has authored over 430 publications and participated as a senior advisor/editor for the WHO 2016 brain tumor classification scheme. He has also served as a chief editor for Brain Pathology (official journal for the International Society of Neuropathology), the 2010 Practical Surgical Neuropathology textbook (second edition now in press), and the 2015 9th edition of Greenfield’s Neuropathology. USCAP has been his professional home since 1992, where he has previously enjoyed many roles, including abstract reviewer, session moderator, companion society speaker, evening session panelist and moderator, short course faculty, molecular special course faculty, and publications committee member.

Dr. Perry also maintains an active surgical neuropathology consult service and is a frequently invited lecturer. Furthermore, he particularly adores the creative side of Pathology, making use of his longstanding passions for both music and teaching. In this respect, he has been featured in several media stories for using "neuropathology songs" in education, including a CD recording of 16 medical ballads and a YouTube male a cappella rendition of ‘Brain Tumor Rhapsody’ set to Bohemian Rhapsody.

Maria Beatriz S. Lopes

Maria Beatriz S. Lopes, MD, PhD
University of Virginia, Charlottesville

Dr. Lopes received her M.D. and Ph.D. degrees at the University of São Paulo in São Paulo, Brazil. She completed her Anatomic Pathology and Neuropathology training at the University of São Paulo followed by a Clinical and Research Neuropathology Fellowship at the University of Virginia in Charlottesville, Virginia, USA.

She joined the faculty of the Department of Pathology at the University of Virginia in 1993 where she is now the Harrison Distinguished Teaching Professor of Pathology and Neurological Surgery and the Chief of the Neuropathology and Autopsy Services. Dr. Lopes has been the Director of the ACGME-accredited Neuropathology Fellowship Program at that Institution since 2003. Her clinical and research expertise is in brain tumors and pituitary pathology with over 150 peer-reviewed manuscripts, 40 textbook chapters, and one book in these areas. She has co-authored several chapters in both the WHO Classification of Brain and Pituitary Gland Tumors since 2000 and 2004, respectively, and was a member of the WHO Consensus and Editorial Meeting of the 4th Edition of the WHO Classification of Tumors of the Pituitary Gland released in 2017.

Fausto J. Rodriguez

Fausto J. Rodriguez, MD
Johns Hopkins University School of Medicine

Dr. Rodriguez is director of the clinical neuropathology service and Associate Professor of Pathology and Oncology at the Johns Hopkins University School of Medicine. He currently serves as co-director of the ACGME-accredited neuropathology fellowship training program at Hopkins. He is also lead author of Neuropathology, in the Diagnostic Pathology series from Elsevier, now in its second edition.

Dr. Rodriguez completed training in anatomic pathology and neuropathology at Mayo Clinic, Rochester, MN, followed by a neuro-oncology research fellowship under a T32 training grant. His clinical and research work aims to identify diagnostic, prognostic, and therapeutic biomarkers and targets in tumors of the central and peripheral nervous system, particularly those that develop in young patients and in the context of inherited tumor syndromes.